JDDonline

Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.

Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.

Early Online

CURRENT ISSUE HIGHLIGHTS

Methotrexate Test Dose Use and Frequency of Laboratory Abnormalities in Patients Initiating Treatment

Published online October 31, 2025

Dermatology providers have traditionally used a test dose (TD) of methotrexate when initiating treatment to assess a patient's predispo...

read more
Elevated Atherosclerotic Cardiovascular Disease Risk in Fibrotic Skin Diseases: Insights From a TriNetX Cohort Study

Published online October 30, 2025

Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of morbidity and mortality worldwide and demands early identificati...

read more
NECASA II: A Practical Algorithm Integrating Skincare in the Management of Adult Female Acne in the Nordic European Countries

Published online October 31, 2025

Acne vulgaris (Acne) is a prevalent inflammatory skin condition that can cause lifelong physical consequences, including dyschromia and...

read more
Rotation Flaps: A Comprehensive Review of Designs and Practical Executions

Published online October 31, 2025

Flap Design and Movement When linear closure along the resting skin tension lines (RSTL) is inappropriate for a given defect, other rep...

read more
Mohs Micrographic Surgery in Female Genital Cancers: A Systematic Review

Published online October 29, 2025

Mohs micrographic surgery (MMS) has emerged as a highly effective and precise treatment for skin cancer, offering exceptional cure rate...

read more
Visualization of Topical Roflumilast Versus Vehicle using Line-Field Optical Coherence Tomography in Healthy Skin

Published online October 29, 2025

Roflumilast is a topical phosphodiesterase-4 inhibitor (PDE-4i) approved by the Food and Drug Administration (FDA) for treating dermato...

read more
Caffeine Supplementation and Hair: A Systematic Review

Published online October 28, 2025

Hair loss is a common dermatologic condition associated with significant psychosocial distress. 1 It has been estimated that 50% of me...

read more
Exploring the Cardiovascular Impacts of Oral Nicotinamide: A Comprehensive Narrative Review

Published online October 27, 2025

Nicotinamide, also known as niacinamide, represents the water-soluble form of vitamin B3, while niacin, or nicotinic acid, constitutes ...

read more
Treatment of Refractory Pruritic Dermatitis in the Setting of Primary Biliary Cholangitis and CREST Syndrome With Upadacitinib

Published online October 20, 2025

CASE REPORT A 66-year-old woman with vulvar lichen sclerosis, Raynaud's phenomenon, and biliary colic status-post cholecystectomy presented for an i...

read more
Management of Hailey-Hailey Disease With Ruxolitinib 1.5% Cream

Published online October 16, 2025

Benign Familial Pemphigus (Hailey-Hailey Disease [HHD]) is caused by a mutation within ATP2C1, the gene encoding the calcium pump of go...

read more
The Impact of Dermatology Community Outreach Programs: Improving Health Equity Through Service

Published online October 16, 2025

Significant racial and ethnic disparities exist within dermatology, including a higher disease burden for numerous dermatologic conditi...

read more
Ethical Dilemma: Who Benefits From Calling an Atypical Junctional Melanocytic Proliferation a Melanoma In Situ?

Published online October 16, 2025

In 2006, an article titled "Who benefits from calling a solar keratosis a squamous cell carcinoma" was published in the British Journa...

read more
Nourishing the Skin: A Review of Diet's Role in Hidradenitis Suppurativa

Published online October 13, 2025

Hidradenitis suppurativa (HS), or acne inversa, is a chronic inflammatory skin condition that is characterized by keratin and bacterial...

read more
Molecular Insights: Immune and Barrier Dysregulation in Seborrheic Dermatitis

Published online October 13, 2025

Seborrheic dermatitis(SD) is a chronic inflammatory skin disease that affects sebaceous areas, typically the face and scalp, with an es...

read more
Colorimetric Scale for Skin of Color to Classify Individuals With Darker Skin to Promote Awareness and Improve Diagnosis and Patient Outcomes

Published online October 9, 2025

To the Editor: In their excellent report on inverse eruptive syringoma, Wang et al (July 2024 issue) 1 state that "this case underscores the impo...

read more
Connecting the Plaques: Exploring the Link Between Dupilumab and Cutaneous T-cell Lymphoma

Published online October 9, 2025

BACKGROUND Recent literature has suggested a link between dupilumab, a monoclonal antibody targeting receptors for interleukin (IL)-4 and IL-13, and...

read more
Assessing Cutibacterium Acnes Susceptibility With Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel Use: Six-Month Analysis

Published online October 8, 2025

Topical therapies such as antibiotics are a mainstay of acne treatment. 1 However, one concern with the long-term use of antibiotic-co...

read more

Current Issue

Explore JDDonline
Subscribe to JDD

Discover the latest research, exclusive articles from leading dermatology experts – Subscribe to the JDD today. Complimentary subscriptions available for US dermatologists, dermatology residents, dermatology nurse practitioners & physician assistants.

Subscribe Now

Latest News

Journal of Drugs in Dermatology JDD featuring Dr. Jacob Beer in JDD Re:View, a discussion of JDD articles and specific topics. Breakthroughs in atopic dermatitis are redefining treatment from the inside out. Discover how new data on race, microbes, and patient preferences are transforming the way we think about AD.

JDD Re:View With Dr. Beer. Atopic Dermatitis Advances: What Every Clinician Should Know in 2025

| Atopic Dermatitis, Featured Articles, JDD Re:View, Latest News, Skin of Color, The Latest | No Comments
Breakthroughs in atopic dermatitis are redefining treatment from the inside out. Discover how new data on race, microbes, and patient preferences are transforming the way we think about AD. In…
Journal of Drugs in Dermatology JDD Article About Skin Barrier Benefits of a Natural Moisturizing Factor and Lipids-Based Moisturizer for Clinically Sensitive Skin

Skin Barrier Benefits of a Natural Moisturizing Factor and Lipids-Based Moisturizer for Clinically Sensitive Skin

| Featured Articles, Latest News, Skincare, The Latest | No Comments
Barrier boost with benefits -  new topical cream raises filaggrin, hyaluronic acid and lipids while improving tolerability A novel topical cream moisturizer produced meaningful biological and clinical improvements in both…
Journal of Drugs in Dermatology JDD Article About An Exosome Regenerative Complex Plus Microneedling Promotes Hair Growth in Subjects With Self-Perceived Thinning Hair

An Exosome Regenerative Complex Plus Microneedling Promotes Hair Growth in Subjects With Self-Perceived Thinning Hair

| Featured Articles, Hair, Latest News, The Latest | No Comments
Exosome complex after microneedling shows promising hair‑regrowth signals in a 30‑patient series In a 30‑subject study (15 men, 15 women; mean age 50.2 years) treated with an Exosome Regenerative Complex+…
Journal of Drugs in Dermatology JDD Article About SAIGE I: Staphylococcus aureus, Immunological, Genetic, and Environmental (SAIGE) Factors Contributing to Atopic Dermatitis and the Use of Ceramide-Containing Skincare

SAIGE I: Staphylococcus aureus, Immunological, Genetic, and Environmental (SAIGE) Factors Contributing to Atopic Dermatitis and the Use of Ceramide-Containing Skincare

| Atopic Dermatitis, Featured Articles, Latest News, Pediatrics, The Latest | No Comments
Think beyond inflammation: SAIGE framing reframes pediatric AD prevention and care A seven‑expert global panel of pediatric dermatologists and dermatologists used a modified Delphi process to produce five consensus statements…
Journal of Drugs in Dermatology JDD Article About Real-World Dupilumab Persistence in United States Children, Adolescents, and Adults With Atopic Dermatitis Over 24 Months

Real-World Dupilumab Persistence in United States Children, Adolescents, and Adults With Atopic Dermatitis Over 24 Months

| Atopic Dermatitis, Featured Articles, Latest News, Pediatrics, The Latest | No Comments
Dupilumab delivers — but many patients need more than monotherapy over time In a US retrospective cohort (OM1 PremiOM™ AD) of 5,200 patients who started dupilumab between 2017-2021 (208 children, 430…

New Innovations of SkinCeuticals and Integrated Skincare

| JDD Highlights, JDD Webinars, The Latest | No Comments
Join Dr. Kachiu Lee, a board-certified cosmetic dermatologist, to learn more about new innovations of SkinCeuticals. Dr. Lee will share the latest integrated skincare science from SkinCeuticals, focusing on products…
View all Derm News

News Topics

JDD Newsletter

Sign up for the JDD eNewsletter for exclusive articles, case reports, Podcast episodes, free CME activities, and more!

Subscribe

JDD Podcast

Wondering about Words: Evidence Based Framing for Improving Treatment Adherence

| Dermatology Podcast Archives, Featured Podcast, JDD Highlights, Podcast Highlights | No Comments
iTunes TuneIn Spotify Hosts: Dr. Adam Friedman and Dr. Steven Feldman Actions speak louder than words…so long as the words inspire, encourage, engage, etc. the actions. This altered adage rings…
Tune In

Follow Us